Core Laboratories (CLB) Misses Q3 EPS by 3c, provides guidance
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.40 --0%
EPS Growth %: +45.5%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +45.5%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $134.4 million versus the consensus estimate of $139.66 million.
GUIDANCE:
Core Laboratories sees Q4 2024 EPS of $0.20-$0.25, versus the consensus of $0.24. Core Laboratories sees Q4 2024 revenue of $128.5-135.5 million, versus the consensus of $134 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- China Rare Earth Group in talks to buy MP Materials shareholder Shenghe Resources - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
